ATP Citrate Lyase

More Information »ATP citrate lyase (ATP citrate synthase, ACLY) is a transferase that catalyzes the conversion of citrate and coenzyme A to acetyl-CoA. ACLY is the key regulator between the high rates of aerobic glycolysis and de novo lipid synthesis exhibited in many types of tumor cells.

ATP Citrate Lyase Products

Product Name / Activity
4609 BMS 303141
ATP citrate lyase inhibitor; orally bioavailable
4615 MEDICA 16
ATP citrate lyase inhibitor; also inhibits FFA1
4962 SB 204990
ATP citrate lyase (ACLY) inhibitor
Related Categories

Quick Order

Find multiple products by catalog number

divider line

Cancer Research Product Guide

Cancer Research Product Guide

Our Cancer Research Guide highlights over 750 products for cancer research. Request copy or view PDF today.

divider line

LinkedIn Updates

Follow Tocris on LinkedIn

Follow us on LinkedIn!

Visit our LinkedIn page for the latest Tocris news, events and updates.